| European Case Law Identifier: | ECLI:EP:BA:1999:T099495.19990218 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 18 February 1999 | ||||||||
| Case number: | T 0994/95 | ||||||||
| Application number: | 82903424.8 | ||||||||
| IPC class: | C07H 21/02 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Oligonucleotide therapeutic agent and methods of making same | ||||||||
| Applicant name: | Molecular Biosystems, Inc. | ||||||||
| Opponent name: | Chugai Seiyaku Kabushiki Kaisha Applied Biosystems, Inc. Hoechst Aktiengesellschaft Zentrale Patentabteilung Gen- Probe Inc. Novartis AG Patent and Trademark Dept. Genta Inc. |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Sufficiency of disclosure (no) | ||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t950994eu1.html
Date retrieved: 17 May 2021